Near infrared spectroscopy; Process Analytical Technology; Liquid form; Low-dose; Validation; Acetominophen
Abstract :
[en] The aim of the present study was first to develop a robust near infrared (NIR) calibration model able to determine the acetaminophen content of a low-dose syrup formulation (2 % (w/v)). Therefore, variability sources such as production campaigns, batches, API concentration, syrup basis, operators and sample temperatures were introduced in the calibration set. A prediction model was then built using Partial Least Square (PLS) regression. First derivative followed by Standard Normal Variate (SNV) were chosen as signal pre-processing. Based on the random subsets cross validation, 4 PLS factors were selected for the prediction model. The method was then validated for an API concentration ranging from 16 to 24 mg/mL (1.6-2.4 % (w/v)) using an external validation set. The 0.26 mg/mL RMSEP suggested the global accuracy of the model. The accuracy profile obtained from the validation results, based on tolerance intervals, confirmed the adequate accuracy of the results generated by the method all over the investigated API concentration range. Finally, the NIR model was used to monitor in real time the API concentration while mixing syrups containing various amounts of API, a good agreement was found between the NIR method and the theoretical concentrations.
Research Center/Unit :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Ziemons, Eric ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Mantanus, Jérôme ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Lebrun, Pierre ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Rozet, Eric ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Hubert, Philippe ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Language :
English
Title :
Acetaminophen determination in low-dose pharmaceutical syrup by NIR spectroscopy
Publication date :
2010
Journal title :
Journal of Pharmaceutical and Biomedical Analysis
ISSN :
0731-7085
eISSN :
1873-264X
Publisher :
Elsevier Science, Oxford, United Kingdom
Volume :
53
Pages :
510-516
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
DGTRE - Région wallonne. Direction générale des Technologies, de la Recherche et de l'Énergie
Commentary :
E. Ziemons and J. Mantanus contributed equally to this work
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
United States Food and Drug Administration (FDA), Guidance for industry PAT-A framework for innovative pharmaceutical manufacturing and quality assurance, FDA, 2004.
Burns D.A., Ciurczak E.W. Handbook of Near-Infrared Analysis 2008, vol. 35. CRC Press, New York. 3rd ed.
Luypaert J., Massart D.L., Vander Heyden Y. Near-infrared spectroscopy applications in pharmaceutical analysis. Talanta 2007, 72:865-883.
Roggo Y., Chalus P., Maurer L., Lema-Martinez C., Edmond A., Jent N. A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies. J. Pharm. Biomed. Anal. 2007, 44:683-700.
Bodson C., Dewé W., Hubert Ph., Delattre L. Comparison of FT-NIR Transmission and UV-vis spectrophotometry to follow the mixing kinetics and to assay low-dose tablets containing riboflavin. J. Pharm. Biomed. Anal. 2006, 41:783-790.
Moes J.J., Ruijken M.M., Gout E., Frijlink H.W., Ugwoke M.I. Application of process analytical technology in tablet process development using NIR spectroscopy: blend uniformity, content uniformity and coating thickness measurements. Int. J. Pharm. 2008, 357:108-118.
Tabasi S.H., Moolchandani V., Fahmy R., Hoag S.W. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy. Int. J. Pharm. 2009, 382:1-6.
Li W., Bagnol L., Berman M., Chiarella R.A., Gerber M. Applications of NIR in early stage formulation development. Part II. Content uniformity evaluation of low dose tablets by principal component analysis. Int. J. Pharm. 2009, 380:49-54.
Rosa S.S., Barata P.A., Martins J.M., Menezes J.C. Development and validation of a method for active drug identification and content determination of ranitidine in pharmaceutical products using near-infrared reflectance spectroscopy: a parametric release approach. Talanta 2008, 75:725-733.
Mantanus J., Ziémons E., Lebrun P., Rozet E., Klinkenberg R., Streel B., Evrard B., Hubert Ph. Active content determination of non-coated pharmaceutical pellets by near infrared spectroscopy: method development, validation and reliability evaluation. Talanta 2010, 80:1750-1757.
Mantanus J, Ziémons E., Lebrun P., Rozet E., Klinkenberg R., Streel B., Evrard B., Hubert Ph. Moisture content determination of pharmaceutical pellets by near infrared spectroscopy: method development, validation and reliability evaluation. Anal. Chim. Acta 2009, 642:186-192.
Rantanen J., Räsänen E., Antikainen O., Mannermaa J.-P., Yliruusi J. In-line moisture measurement during granulation with a four-wavelength near-infrared sensor: an evaluation of process-related variables and a development of non-linear calibration model. Chemom. Intell. Lab. Syst. 2001, 56:51-58.
Sandler N., Rantanen J., Heinämäki J., Römer M., Marvola M., Yliruusi J. Pellet manufacturing by extrusion-spheronization using process analytical technology. AAPS Pharm. Sci. Tech. 2005, 6. Article 26.
Blanco M., Cueva-Mestanza R., Peguero A. Controlling individual steps in the production process of paracetamol tablets by use of NIR spectroscopy. J. Pharm. Biomed. Anal. 2010, 51:797-804.
Eustaquio A., Blanco M., Jee R.D., Moffat A.C. Determination of paracetamol in intact tablets by use of near infrared transmittance spectroscopy. Anal. Chim. Acta 1999, 383:283-290.
Ito M., Suzuki T., Yada S., Nakagami H., Teramoto H., Yonemochi E., Terada K. Development of a method for nondestructive NIR transmittance spectroscopic analysis of acetaminophen and caffeine anhydrate in intact bilayer tablets. J. Pharm. Biomed. Anal. 2010, 53:396-402.
Blanco M., Castillo M., Peinado A., Beneyto R. Determination of low analyte concentrations by near-infrared spectroscopy: effect of spectral pretreatments and estimation of multivariate detection limits. Anal. Chim. Acta 2007, 581:318-323.
Chalus P., Roggo Y., Walter S., Ulmschneider M. Near-infrared determination of active substance content in intact low-dosage tablets. Talanta 2005, 66:1294-1302.
International Conference on Harmonization (ICH) of Technical Requirements for registration of Pharmaceuticals for human Use, Topic Q2 (R1): validation of analytical procedures: Text and methodology, Geneva, 2005.
International Conference on Harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use, Topic Q9: Quality Risk Management, Geneva, 2005.
Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal-part I. J. Pharm. Biomed. Anal. 2004, 36:579-586.
Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L., Rozet E. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal-part II. J. Pharm. Biomed. Anal. 2007, 45:70-81.
Bouabidi A., Rozet E., Fillet M., Ziemons E., Chapuzet E., Mertens B., Klinkenberg R., Ceccato A., Talbi M., Streel B., Bouklouze A., Boulanger B., Hubert Ph. Critical analysis of several analytical method validation strategies in the framework of the fit for purpose concept. J. Chromatogr. A 2010, 1217:3180-3192.
Acetaminophen Capsules, United States Pharmacopoeia USP32NF27, The United States Pharmacopeial Convention, Rockville, 2009, p. 1338-1390.
European Medicines Agency, Draft: guideline on the use of near infrared spectroscopy by the pharmaceutical industry and the data requirements for new submissions and variations, EMEA/CHMP/CVMP/QWP/17760/2009 Rev 1.
Analytical Methods Committee Uncertainty of measurement: implication of its use in the analytical science. Analyst 1995, 120:2303-2308.
Eurachem/Citac Guide Quantifying the Uncertainty in Analytical Measurement 2000, 2nd ed.
CB EA-4/16, EA guidelines on the expression of uncertainty in quantitative testing. 2004. http://www.european-accreditation.org/.
Marini R.D., Chiap P., Boulanger B., Rudaz S., Rozet E., Crommen J., Hubert Ph. LC method for the determination of R-timolol in a S-timolol maleate: validation of its ability to quantify and uncertainty assessment. Talanta 2006, 68:1166-1175.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.